Retrospective analysis of recurrence patterns and clinical outcomes in grade I–III meningiomas after surgery
Surgical Neurology International · 25.04.2025 · 16 · 149
DOI: 10.25259/sni_32_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Neurology International, online erschienen am 25.04.2025. Verfasst von Yuli Felistia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program of Medical Science, Faculty of Medicine, Airlangga University, Surabaya, Indonesia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The objective of this study was to evaluate the outcomes of meningioma patients with the World Health Organization (WHO) grades I–III who underwent surgical resection and identify factors influencing recurrence and survival.
Methods
This retrospective study included patients who underwent surgery for meningioma at the National Brain Center Hospital between January 2020 and December 2022. Clinical characteristics of patients with recurrence, such as gender, age, preoperative Karnofsky Performance Scale (KPS), grading, and history of radiotherapy, were recorded. The recurrence time was assessed within 2 years post-surgery. Magnetic resonance imaging or computed tomography imaging results were used to determine meningioma location, while the WHO grading was based on pathological findings. Survival analysis of recurrence across different grades was performed using Kaplan–Meier curves.
Results
Of the 184 patients who had surgical resection for meningioma, 53 (28.8%) experienced recurrence. The recurrence group consisted primarily of women (81%), with a preoperative KPS > 70% (83%), Simpson grading II–III (60.3%), WHO grade II (39.6%), and meningiomas located in the convexity (24.5%). Most patients (81.1%) had no history of radiotherapy, and 64.15% had two or more resections. The average recurrence-free period after surgery was 17.95 ± 20.39 months. Mortality due to recurrence was most common in the WHO grade II patients (11.1%). Kaplan–Meier curves showed differences in recurrence between grading subgroups, with the WHO grade III meningiomas exhibiting the highest recurrence rate and the worst prognosis.
Conclusion
Higher-grade meningiomas are more likely to recur and result in poorer outcomes. Further research is needed to investigate tumor recurrence at the molecular level. A multidisciplinary approach to treatment improves outcomes and reduces complications associated with recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral Program of Medical Science, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
- Department of Neurology, National Brain Center Hospital, Jakarta, Indonesia.
- Department of Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
- Department of Medicine, Faculty of Medicine, Public Health, and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.
- Department of Neurosurgery, Faculty of Medicine, Airlangga University, Surabaya, Indonesia.
- Gastroentero-Hepatology Division, Department of Internal Medicine, Faculty of Medicine, Dr. Soetomo Teaching Hospital, Airlangga University, Surabaya, Indonesia.
Zitieren
APA
Felistia, Y., Amanda, N. F., Hendrawan, F., Susanto, N. H., Al Fauzi, A., & Miftahussurur, M. (2025). Retrospective analysis of recurrence patterns and clinical outcomes in grade I–III meningiomas after surgery. Surgical Neurology International, 16, 149. https://doi.org/10.25259/sni_32_2025
Vancouver
Felistia Y, Amanda NF, Hendrawan F, Susanto NH, Al Fauzi A, Miftahussurur M. Retrospective analysis of recurrence patterns and clinical outcomes in grade I–III meningiomas after surgery. Surgical Neurology International. 2025;16:149. doi:10.25259/sni_32_2025
BibTeX
@article{Felistia2025,
author = {Felistia, Yuli and Amanda, Nadira Fildza and Hendrawan, Fandi and Susanto, Nugroho Harry and Al Fauzi, Asra and Miftahussurur, Muhammad},
title = {Retrospective analysis of recurrence patterns and clinical outcomes in grade I–III meningiomas after surgery},
journal = {Surgical Neurology International},
year = {2025},
volume = {16},
pages = {149},
doi = {10.25259/sni_32_2025}
}
EUVIMED